Harter Secrest & Emery Helps Maxim Group Close $14.6 Million Offering

Harter Secrest & Emery LLP, a full-service business law firm with offices throughout New York, recently represented Maxim Group in an underwritten, confidentially marketed public offering of shares of common stock and warrants of Milestone Scientific, raising total gross proceeds of approximately $14.6 million (before underwriting discounts, commissions and estimated offering expenses). The HSE Securities and Capital Markets team for the transaction included Alexander R. McClean, Margaret K. Rhoda, and Kevin R. Pregent

Maxim Group, a leading full-service investment banking, securities and wealth management firm headquartered in New York, NY, provides a full array of financial services to a diverse range of corporate clients, institutional investors, and high net worth individuals.

Milestone Scientific Inc. is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone’s computer-controlled systems such as the DPS Dynamic Pressure Sensing Technology are designed to make injections precise, efficient, and virtually painless.

Harter Secrest & Emery is recognized within Upstate New York as a leader in the securities and capital markets industry. The firm has represented issuers and underwriters in over 60 public offerings, with clients ranging from businesses seeking start-up capital to Fortune 500 companies. The firm’s securities practitioners assist clients with private and public offerings of securities, ongoing regulatory compliance and reporting, proxy solicitations, tender offers, and securities litigation and arbitration before the Securities and Exchange Commission, self-regulatory organizations, and state and federal courts.

Attorney Advertising. Prior results do not guarantee a similar outcome. This publication is provided as a service to clients and friends of Harter Secrest & Emery LLP. It is intended for general information purposes only and should not be considered as legal advice. The contents are neither an exhaustive discussion nor do they purport to cover all developments in the area. The reader should consult with legal counsel to determine how applicable laws relate to specific situations. ©2022 Harter Secrest & Emery LLP